NCT04121065View on ClinicalTrials.gov

Role of ADA SNPs in Subjects With Relapsing Multiple Sclerosis (RMS)

RecruitingOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

September 7, 2020

Primary Completion Date

October 31, 2024

Study Completion Date

June 30, 2025

Conditions
Relapsing Multiple Sclerosis
Interventions
PROCEDURE

Blood withdrawal

Blood withdrawal of maximum 60 ml performed to each enrolled patient during the study for primary and secondary endpoints evaluation.

Trial Locations (1)

86077

RECRUITING

IRCCS Neuromed, Pozzilli

All Listed Sponsors
lead

Neuromed IRCCS

OTHER